Gerontology Investigators Press An Ambitious Agenda

Sidebar: WHERE GERONTOLOGISTS GET TOGETHER ACCESSING AGING ASSETS Despite a substantial increase in the flow of financial support for gerontological research during the past several years, ambitious investigators of aging-associated phenomena continue to lament that their field is underfunded. One such investigator is Denham Harman, a professor, emeritus, at the University of Nebraska College of Medicine in Omaha. The 78-year-old

Written byKaren Kreeger
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Despite a substantial increase in the flow of financial support for gerontological research during the past several years, ambitious investigators of aging-associated phenomena continue to lament that their field is underfunded.

One such investigator is Denham Harman, a professor, emeritus, at the University of Nebraska College of Medicine in Omaha. The 78-year-old Harman for many years has argued that aging research deserves far more attention and financial support than it traditionally has received--especially because the United States population, according to demographic statistics, is rapidly getting older. "We need to spend more money on basic biomedical research on aging to go after its basic causes," he asserts.

Harman acknowledges his gratification at seeing significant funding gestures in the past year alone by such private sources as the Charles A. Dana Foundation in New York and the Glenn Foundation for Medical Research in Santa Barbara, Calif. And he was heartened most recently ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies